Editors’ Note: This is the transcript version of the podcast. Please note that due to time and audio constraints, transcription may not be perfect. We encourage you to listen to the podcast, embedded below if you need any clarification. We hope you enjoy!
This week we are joined by Eric Leslie Co-Founder of Cheeba Chews to discuss :
- 2009 Origin Story
- Product Innovation as a Market Leader
- Minor Cannabinoids in Edibles
- New Product formulation journey
About Cheeba Chews – Born in Colorado in 2009, Cheeba Chews is known far and wide for its consistently delicious award-winning confections. From original chocolate and caramel chews to newer offerings—such as the Sleepy Time and Trifecta lines of low-calorie, fat-free taffies featuring an entourage of emerging cannabinoids like CBG and CBN—Cheeba Chews’ unique products tap into the increasingly in-demand cannabis wellness market. With a focus on quality and consistency, consumers trust Cheeba Chews to deliver in taste and reliability. Cheeba Chews products are currently available in medical and recreational markets in California, Colorado, Massachusetts, Nevada and Oklahoma. Whether it’s focus, feel-good vibes or a restful night, we got Chew. Learn more: cheebachews.com
At Eighth Revolution (8th Rev) we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
The Dime is a top 50 Cannabis Podcast
Contact us directly at [email protected] Bryan Fields: @bryanfields24 Kellan Finney: @Kellan_Finney
[00:00:00]Bryan Fields: What’s up guys. Welcome back to that episode of the dime I’m Brian Fields. And with me as always is Kellen Finney. And this week we’ve got a very special guest Eric lessee of Cheeba chews. Co-owner how are you doing Eric? Thanks for taking
[00:00:13]Eric Leslie: the time. Yeah, thanks for having me guys doing really well excited.
[00:00:16]Bryan Fields: Dive in Kaelin. How are you? I’m
[00:00:18]Kellan Finney: doing, I’m doing great, really excited to talk to one of the first west coast brands out here and just, you know, represent, um, also as beautiful spring weather. So really can’t go wrong. How are you, Brian? How’s New York. I’m doing well. Thanks for
[00:00:31]Bryan Fields: the daily weather updates. So Eric, we are excited to dive in.
[00:00:34] So for our listeners that aren’t familiar about, you, can you give a little background about you and how you got into the Canada?
[00:00:40]Eric Leslie: Uh, yeah, so, uh, Cheeba chews born out of a home kitchen, 2009, um, in Colorado. And, uh, you know, our founder, James, you had some leftover trim from a home grow. And I said, what can I do with this?
[00:00:56] Um, and, uh, Play with a bunch of different [00:01:00] candies and found taffy. And the viscosity really held, you know, the cannabis extract really well. And, you know, at the time, um, you know, that he’s a lifelong friend of mine, he reached out and said, Hey, I had this taffy thing. You really got to try it. Um, and, uh, hooked me up with this little, this little piece that looked like, you know, uh, Piece chocolate taffy.
[00:01:21] Uh, simple enough. Can’t do any harm. Um, the one I tried was 70 milligrams, but did not eat the whole piece. Uh, I am a lightweight, um, but try to piece of it in, you know, within 30 minutes, man, I felt something I’d never felt, you know, smoking cannabis. And, um, you know, from that moment on I was hooked. I was like, yeah, you’re onto something here, but, uh, what do we do next?
[00:01:43] And I, I think the next conversation is what do we call it? Uh, And, uh, you know, found Cheeba chews. Wasn’t named that really stuck. We had a whiteboard of, of possibilities and, uh, we pegged on the whiteboard and said, you know, let’s go with Cheeba chews. Um, and, uh, the legend was born. [00:02:00] What were those early days of.
[00:02:04] Yeah, it was, um, really like the wild, wild west. Right. You hear that a lot. It’s a little bit of a cliche, but it’s really true. Um, you know, I remember just, you know, even just walking around Denver, Colorado, it’s like, it’s just different, right? Like weed is legal, even in a medical sense, you know, it felt different.
[00:02:22] Um, you know, there weren’t a whole lot of regulations. Nobody had defined what a dose was, um, edibles at the time, it was a crap. You know, you get this cookie or this brownie, or a piece of cheesecake in a bowl. What do I do with it? Um, half the time it works, the other half of the time it’s done. Um, and so there are really no standards in place.
[00:02:44] I mean, people love flour and, you know, cannabis was what it was. And, um, you know, I think bringing in edible. Um, you know, our taffy with Cheeba chews to the market, it really totally set a standard. Um, and, uh, it was a lot of [00:03:00] fun because we were able to set the standards early on. Um, and, and I th I don’t even think we knew at the time what we were really doing.
[00:03:07] Um, as far as. Creating a standard for an entire industry. Uh, we’re just kinda going with gut instinct, um, and, uh, you know, those days, uh, loose regulations, uh, there are a lot more fun, uh, than dealing with, uh, the hoops. I’m going to jump through now to say that. Yeah, I can only imagine. So
[00:03:24]Kellan Finney: being like one of the early edible brands in.
[00:03:27] One of the first states, um, there’s always been kind of a stigma associated with the animals, especially early on. I remember there was a couple really negative media stories that kind of came out associated with like dosing and those kinds of things. So, so what was it like kind of being on the other side of that, those media stories and every.
[00:03:44] Building a brand, knowing you’re trying to do everything the right way and still hearing kind of like this other, other side of the story, you know
[00:03:51]Eric Leslie: what I mean? Yeah. The biggest thing, um, I think it did for us is, is even on a personal level, it’s just taught you [00:04:00] resiliency. Um, you know, because, you know, we got beat up a lot, you know, in the early days, you know, because you know, there’s a lot of scare tactics, you know, I think the worst one.
[00:04:09] You know, Halloween every year. Now it’s a joke and we all like, you know, you know, make fun of it early on. It’s really scary. Like we did no promote, no promotion, no marketing, um, around Halloween because, um, the, the industry was so scrutinized at the time. Um, and we were really worried, um, you know, what the general public was going to think, and people really didn’t understand the power of edibles and you can overdose, but your overdose is like, whoa, way too hot.
[00:04:38] I’m going to take a nap. Like it’s not something that that’s going to cause very many issues besides I got to eat some more food than I need to sleep because, you know, I, I ate too much wheat, but because there was so much unknown at the time, uh, we had to be really careful, you know, we, we did, uh, I think an excellent job.
[00:04:55] Of walking that tight rope of, you know, being a, [00:05:00] uh, provocative, uh, you know, exciting brand, but also being responsible, um, you know, and making sure that consumers knew that you’re still dealing with something that’s going to intoxicate you. Um, while we want to have fun cannabis is a fun product. Uh, we also have to be very accountable and responsible.
[00:05:19] Uh, so I think it was, it was difficult to navigate. There’s more frustrating because a lot of the scare tactics were completely outlandish, but how can you speak to that without proving it? And I think our industry just needed time to prove it, um, and, and make sure that we’re not over-regulated and allow us to kind of set the standard and not allow regulators to define what we’re going to be.
[00:05:42] Were there
[00:05:42]Bryan Fields: moments during the early days that gave you kind of hesitation to kind of dive in? I may be those thoughts thinking like, is this really gonna work? And then take us through the other side of the coin when you read. This is really happening. We’ve really got some brand staying power here.
[00:05:56] People are really starting to take to.
[00:05:58]Eric Leslie: Yeah, I think it was [00:06:00] probably 2010. We won the high times cannabis cup with our DECA dose under 75 milligrams, 10, 10 grand piece that may be rocked you. Um, I think there were shops at the time that that made medical patients sign a waiver before they would buy that product because it was just knocking people out at the time.
[00:06:21] Um, yeah. When that caught waves in high times and such a big part of what we did early on. Which is funny because you know, the evolution of high times, you know, and how they have transitioned, like in what they’ve become early on, man. Like the legend of Cheeba chews was genuinely born through high times because that magazine print over in Alabama, uh, people are like, what is this thing?
[00:06:45] I got to try it. Um, and, uh, you know, somehow they found it and they did try it. And I think that. That, uh, that genuine advocacy is really what built the brand like Lao the product to prove it for you. Um, I think that was the most important part of it. [00:07:00] Like we wanted, we always did, like, I never did stuff like this early on.
[00:07:03] We always worked ghosts behind the brand. Like you could never get us on camera. Um, and many reasons why. Great days. Uh, you know, so we still have family protect, but also we really want the product to speak for itself. Um, and, uh, we didn’t want to put the focus on the people behind it. We want people to focus on the product and the brand experience, um, and, and that worked for us.
[00:07:26] Um, and I think as we saw the industry mature and kind of catch up to. Doin we realized like, Hey man, we got a lot of really great experience, man. We got some great street credit and industry credibility. I think we need to start talking a little bit more and let people know, like here’s a brand that’s been through it.
[00:07:42] Maybe we should listen to some of the things they have to say.
[00:07:45]Kellan Finney: Yeah. I think everyone has a decadent story, at least. Um, from, from in my little social network, it’s like a. Your college brownie Ray and everyone eats one is like, that was an experience. So, um, I wanna, I’m curious on, like, you guys had the DECA dos [00:08:00] create that awesome brand awareness kind of plan your guys’s flag in the industry.
[00:08:04] What was the next step from there? And like, how did you guys kind of dive into different product formulations and, and where did you guys decide to steer it from that.
[00:08:14]Eric Leslie: Good question. We rested on our laurels for far too long. Um, and when you get, you know, um, uh, a group of people together like us, and we’re small, there’s three of us at the ownership level and we’ve been there since the beginning.
[00:08:27] Um, our backgrounds are not in a big business scaling and growing. Um, you know, our founder, James worked in construction. Um, my partner, Dave owned a hot dog cart. Uh, and so restaurants on the east coast. Um, I have a marketing background, but uh, not in food product. Right. So, um, you know, w when we launched it, uh, you know, really didn’t know where we were going.
[00:08:52] Um, and I think it was just our resiliency to continue to respond, um, that that really gave us, you know, what our identity was. Um, and [00:09:00] when you find a formulation that works, and you’re not like, you know, 10 years. 2030 year seasoned professionals state. This is what we do next. You kind of hold on to that lightening in a bottle.
[00:09:10] Um, and so for years we just stayed who we were and because Steve, a hybrid chocolate taffy with caramel in between, um, I think it was probably 2014 or 15. When we decided, Hey, he ever like, got up to us and they’re kind of getting ahead of us now, what are we going to do next? Um, and that’s when we started playing with fruit taffies, and we really wanted to own the taffy lane.
[00:09:33] Uh, we jumped over to California at the time. Uh, had a lot of success in the. Early gray days, um, in the traditional market, which is what you should be calling it. Now don’t call it anything else, traditional market. Um, we’ve had a lot of success there, so we weren’t doing a lot of skew or product innovation, because again, you got three dudes at the top, um, you know, just kind of learning their way.
[00:09:56] We weren’t looking to grow a multi-state operation. We were doing. [00:10:00] Based off of gut instincts. Here’s what we’re going to do next. And then we’ll figure it out when we get there. Uh, by the time we got there, we realized everybody caught up to us when you start doing things differently. Uh, so after we launched our fruit taffy, um, we really started looking at our minor cannabinoids.
[00:10:16] Um, and it’s hilarious because we started talking CBN back in 2015. Uh, we had the product ideas, um, w we had some R and D and. But a key low of a CBN at the time was 40, $50,000. Um, and there’s no way we could, um, afford to pay for it. Just don’t keep our product in a cost effective manner down to consumers and the scarcity part, right?
[00:10:42] You weren’t sourcing CBN from legitimate sources to be able to put into a regulated. So really the booth for us happened 2018 farm bill hits, um, have, is everywhere. CBD is now the new craze. Uh, it heals everything and everybody wants it. Uh, farmers [00:11:00] quickly realize there’s a little bit of a bus to that.
[00:11:02] Boom. And they had a lot of. Product. Um, and then they said, what do we do with this product? And it really gave us an opportunity to dive into extracting minor cannabinoids. It’s so expensive to do that, that you weren’t doing it in a regulated system. You’re taking this very valuable product that you would extract THC from and trying to find CBN or CBG or any other minor cannabinoids.
[00:11:24] But because we had such an influx of Product available on the hemp side. And it was legal. We started to find the ability to extract CBN CBG, uh, from him. Um, and, and because of the way regulations were specifically in Colorado, it’s just an ingredient. Uh, so I can import, you know, have derived CBN and infuse it into my THC products because just ingredient Um, and, and that’s where we really found, um, you know, a revitalization of our idea. Um, specifically launching our sleepy chew. It was [00:12:00] 2018. Um, in branding it’s sleepy chew 20 pack, a product with five milligrams of THC and 2.5 CBN in each shoe. Um, it took. Hold quickly. Um, and, uh, you know, I remember looking at it, you know, we, we took a gamble, like our first kilos of CBN was $40,000.
[00:12:20] Um, but we knew we had to do something. Um, and I’ll tell you what the funny part about it is. You know, looking at it now, four years later, you can find CPN for five, $6,000. Now, like that’s how quickly that it’s, uh, you know, uh, you know, what’s the demand for a product and we’ll find a way to supply it. Uh, so Hep gave us the pathway.
[00:12:41] Uh, we had to be early in the model. Um, cause we knew it was an opportunity to diversify and to do something different from THC. Um, and it really relaunched the brand, um, and kind of expanding ourselves in the wellness category.
[00:12:55]Bryan Fields: I’m really glad you shared that. And I want to dive into the bomb like a little later, but I want to stay with the formulation [00:13:00] aspect.
[00:13:00] So how does that work when you want to start a new product? Is it, we want to stay with this flavor and we’re thinking this cannabinoid and then is it just adjusting the doses? I mean, take us through that experience. What that.
[00:13:11]Eric Leslie: So so far, right in, in, you know, looking forward is a totally different story.
[00:13:15] But so far, I think we’re really, really clear that we knew what CBS. Was doing for us. And we knew the lay we could create with the sleep aid, you know, ju um, so that was really easy for us. What it came down to was, uh, ratios. We knew we were dealing with specifically in recreational markets, a cap of a hundred milligrams, THC.
[00:13:36] We also know you don’t need 10 milligrams of THC in your CBN product to fall asleep. Um, but we also know. THC CBN, uh, their amplifiers for each other, right? You really shouldn’t look at one without the others specifically, if you’re looking for a CBN product to really do its job, you need that entourage effect.
[00:13:56] And so we looked at, can we do a lower dose of THC [00:14:00] to help amplify that? Low dose of CBN. Um, we sprinkle it in a little bit of melatonin that helped us from a regulation standpoint. I could then make the claim of sleep aid. Uh, cause I had a little melatonin, just two milligrams though. It wasn’t, you know, it was a very small amount, but then I could make those claims, you know, those are the hurdles you got to jump through in regulated markets is.
[00:14:23] You’re not making any health claims. When it comes to cannabis, you have to be really creative with how you’re going to market because consumers, the more they become educated, the more they’re looking for specific products to solve specific issues. Um, and, and so in order to make any sleepy product, we sprinkled in local relative.
[00:14:41] Um, and then let the CBN amplified by THC do its job. Um, so the really hard stuff ride really hard is you gotta test it, man. You gotta take the product and see what ratios work. Um, so I volunteered, I said, guys, you know, this is a tough job, but, uh, I’ll do it. You know? And, and then once we [00:15:00] find a formulation that works internally, you know, we, we, we have a great network of budtenders and buyers.
[00:15:05] And we then go through the RD process of sampling out and finding the ratio that most consistently works for people. Um, and that’s really how we launch our products is, is getting that feedback. There’s no reason. Depth and scientific data to tell us these things, because we’re not studying it on a federal level.
[00:15:23] We are studying it though within our industry. Um, we knew the power of CBD way before a hemp bill, because we saw it from the testimony of our consumers. Uh, the same thing we’re seeing what the CBN product and you know, our trifecta, it’s the testimony, the valid. From consumers and in our partners that are providing us the insights to say these things are making real impacts in people’s lives.
[00:15:49]Kellan Finney: You say what? I want to see what the formulation I have. Uh, I’m curious on how much strains affect the, the entourage effect with, with CDN, right? So THC, are you guys [00:16:00] using specific strains? Have you noticed, is that something that affects the formulation and you have to try to stay within like these four strains from availability
[00:16:07]Eric Leslie: perspective.
[00:16:09] Good question. Um, so the way that we build, uh, our, our wellness products is through distillation of tea. So then the turpines, aren’t going to be those out because we want to be precise and we want it. This is the science behind doing this. And, you know, w we are also doing Roger products, which I think, um, has a totally different lane where you’re preserving your terpene and the food dynamic of strain.
[00:16:35] That’s super powerful. And I think there’s a, there’s, there’s a huge growth opportunity in the maturation of consumers to, to buy those products with our wellness. We want to strip it down to an isolate individual cannabinoids and then reintroduce them together. And the power of doing that. That’s why the, the endless research, right?
[00:16:53] The R and D process of saying, can I add more CVN? What does it do? Can I add less by stripping the [00:17:00] THC down and distilling it to just the THC 90, 95%? We control the levers of dosing to really zone in on the effects. We’re trying to, uh, we’re trying to, you know, have with that product experience and so wellness, we really strip it back on THC.
[00:17:18] And then we, re-introduced a very specific cannabinoids. To judge the effects and the impact we’re looking for from, from that wellness product. I think it’s really admirable
[00:17:29]Bryan Fields: that you give yourself to science for that and dedicate yourself out of the team. I gotta, I gotta hand it to you that not, there’s not many people that are willing to put themselves
[00:17:35]Eric Leslie: in the line with those, our job rather, it’s our
[00:17:37]Bryan Fields: job.
[00:17:38] So continuing on that path, obviously CBN and sleep Connor are synonymous together and that’s an easy one. And then I’m in really impressed with the trifecta because now your, your team’s taking it up another level, right? Having two variables is hard. Three is even harder. And besides the economic aspect, which we can get into, take us through that formulation.
[00:17:56] You know, how, how did that work?
[00:17:58]Eric Leslie: Yeah, that’s a great, great question [00:18:00] as well. Uh, luck buddy. Um, sometime you just gotta get lucky. No, um, very honestly I found a really small study, um, and I couldn’t find it today. I have to go searching in my emails to find the link for it, but I found a study that looked at THC CBD and CBG for anti-anxiety, um, really small.
[00:18:24] Road study, right? Not on humans. Um, but I saw this study as I was researching these, these different cannabinoid combinations. I’ve always been a huge fan of the one-to-one THC CBD because of the balancing effect that CBD gives you for the THC high, like the focus, uh, with that, you know, that, that high energy you get, it was always a favorite of mine early on.
[00:18:48] And so I was searching through, you know, w well, what are the health benefits, you know, of CBG. Um, and when I found this study that showed those three connection points and looked at where we [00:19:00] were at in society, this was 2020, uh, when we introduced it, we’re high anxiety, highly stressed, we’re all quarantine.
[00:19:08] We got a lot of social issues going on. I found a product mix. And so what we decided to do was stick with the 20 pack concept, you know, that we have with our sleepy choose it’s a wellness product. We’re not looking to get you high with a max amount of THC. I can put in a dosage of looking at my cannabinoid combinations and how can I create a solution that causes different effects for people.
[00:19:32] And so we infuse five milligrams of THC, five milligrams of CBD. Five milligrams or CBG. Um, that again was, was a testing. I did, you know, for myself and, you know, internally and I, man, okay. I’m feeling this subtle buzz of this THC, but I’m also experiencing great mental clarity and focus. Um, and, and that uplifting euphoria.
[00:19:54] Right. Um, and I said, if I’m feeling this, um, how’s everybody else feeling, and I [00:20:00] got that consistent feedback and I saw. The entourage and the amplification of what CBG CBD paired with THC can do. Um, and, uh, we started developing, how can we sell this? Because I can’t make health claims. I have no other nutraceuticals that are putting into my trifecta.
[00:20:18] How do I sell it? And so, you know, we branded it as our be happy taffy, uh, very broad and general, right. Um, and how you’re going to categorize that. And I said, in order for people to understand the effects, this product will have on them, they have to try it. Brian, I gave you guys, um, you know, samples or.
[00:20:38] Let’s see if it works for you, man. Like you tell me if this works and that’s exactly what we had to do, um, to launch that product. Sleepy was really clear. You guys, with messaging, you just have to look at the product, you know what you’re gonna do. Um, it required heavy sampling at the bud tender buyer level to build that advocacy that, that trifecta man, like it is.
[00:20:58] To sleepy, [00:21:00] because sleep is such an easy, clear, cut demand, but it’s continuing to rise and pool through because when people connect, um, you know, a cannabinoid to the internal system and find that mix that really works for them, um, you don’t go away from it. And trifecta has connected with so many people that, that testimony.
[00:21:20] Um, you know, I had a guy early on, he must have dude, this is exactly what I was looking for from cannabis. When I started years ago, experiment it, you found it. I want to read a book, stay focused, but also smile my ass off the entire time through it. That’s over and over. I continued to get that advocacy and that’s what created the clarity of like, okay, this is the impact this product can have on.
[00:21:43]Bryan Fields: I think that’s so perfectly well said. And when I took the edibles, which is my preferred way of taking it, I was unsure of what to expect. And I felt that nice light buzz, massive smile on my face that could not come off as really dire focus. And then in I’m starving all of a [00:22:00] sudden, like it just kicked in.
[00:22:00] And I was wondering, I was like, I wonder if this combination kind of elicits my metabolism to kind of get off the charts. When someone asks me, you know, what it was like, I was like, I just wanted to smile the whole time and just couldn’t kick it off. And I really, really enjoyed it. So how hard is that to kind of surface the different ingredients to build that bomb when you’re forecasting out?
[00:22:18] Because like we said, with CBN, if you’re coming in at like 50 at QO, and now you’re doing multiple cannabinoids plus VPN at the same time, it’s a lot of money to front out without knowing, Hey, we’re not sure how to market this. We’re not sure people were going to understand. And then we have to lay out a bullet of cash.
[00:22:33] So how does that work from a.
[00:22:36]Eric Leslie: So we’ve been able to rely on, um, our, the credibility of our brand, uh, potent consistent discreet was the, the original identifiers for Cheeba chews. Um, uh, fortunately for us, the entire industry now is potent consistent and discreet. Uh, so everybody kind of. Came up to the standards that we set.
[00:22:56] Um, but, but having that early credibility, um, I [00:23:00] think helped, uh, from a, uh, experimentation standpoint, she would choose providing this product and standing behind it. Um, there’s some legitimacy to what’s happening here. Um, and I think that was really important from a program perspective is that we always have maintained the credibility of who we are, um, in the stuff we put out.
[00:23:18] We’re not trying to put out a gimmick. We’re really genuinely. Behind making a difference for people and making a difference in people’s lives. We’re not here to maximize profits and sell the business for as much as we can get. We’re a for-profit business. You know, we have to, you know, provide for our families.
[00:23:34] Uh, but, but the driving cause behind the business has always been to make an impact in people’s lives. Um, it, it, and that’s exactly, what’s the intention behind, you know, sleepy and then obviously trifecta being a market leader. Doesn’t always be you’re the top guy and selling products. Uh, it means you’re willing to walk out on that ledge and risk yourself for what you believe in, and tell the rest [00:24:00] of the industry to come with you, because this is where we’re going.
[00:24:02] And that’s exactly what we did in wellness. We knew who we were as an original Cheeba chew, a hundred milligrams. Even back in the days when we’re 70 milligrams and 1 75, we set a standard that the industry needs to evolve. Um, you know, I’ll, I’ll say it here, cause I’m sure you guys have heard of Brian probably over on the west coast.
[00:24:21] You know, THC in California is co is called hotdog. Um, because it’s everywhere, right? Everybody has it. And it just is what it is, what makes it different from the other product that has a hundred milligrams of hot dog water? Um, it truly genuinely is the innovation of these minor cannabinoids. Turpines the way that we.
[00:24:42] Leveraging THC, but also infusing it with other, um, you know, cannabinoids is how the industry is going to mature and continue to innovate and grow. Uh, we don’t know our ceiling as an edible industry because we’re still trying to figure out what these ratios and combinations can truly do for people.
[00:24:59] Because from a wellness [00:25:00] perspective, we can make a huge difference from just getting people high, to really helping people on an everyday basis.
[00:25:08]Kellan Finney: How much does the volatility of the economics impact the kind of where you guys settle from a dosing perspective, say you’re like, Hey. Two milligrams works. I get a good feeling.
[00:25:18] Three is a little better, but because we see this significant volatility in CBG pricing where last month it was
[00:25:25]Eric Leslie: maybe a
[00:25:26]Kellan Finney: significant factor more than it is this month. How do you guys kind of balance all of those factors together to continuously produce stable
[00:25:33]Eric Leslie: products? I think. The benefit we have working both in recreational medical markets is we can launch with a recreational market that has the caps and the potency, um, and work in those ratios first at a more respectable manner.
[00:25:51] A really good example. Is, um, our sleepy choose, you know, where 2.5 milligrams when we started, um, we have [00:26:00] doubled that dosage because of the CBA prices coming down. We’ve pulled out even more melatonin. Um, and, and there’s maybe a milligram of melatonin, but we’ve doubled the amount of CDN in there, right.
[00:26:11] Because the affordability. NAB annoyed allowed us to be able to infuse more into our products. So, um, as, uh, the demand for these minors, um, grow the price comes down and it gives us the ability that to introduce more of the miners into each, into each, you know, to, but also then we can play on the medical side.
[00:26:30] Um, you, Oklahoma is a really good example. Our best selling product in the entire market is our green Hornick Dhabi. Um, you know, our great, which is our good night. Great. Um, and it’s double the potency of our Cheeba chews sleepy, right? The sleepy chew in every other market is number one in Oklahoma, which is straight medical.
[00:26:50] It’s far in a way the Greenheart at gummy, uh, the goodnight gray and it’s 10 and five on that product. Um, which for me is way too [00:27:00] much, right? Like I’m not. 10 milligrams, THC. Cause I’m going to be groggy in the morning and I’m not looking for that. I don’t be fresh. That’s why I only like the five, but because, um, you know, we can introduce it on the recreational side.
[00:27:11] We can increase dosage on the medical side say, well, what impact does this have? And what sort of demand is there for it? We all have tolerances, right? So if we’re taking the product over and over, um, our tolerance is going to build up. Unless we take a break from it. Um, and what we saw in Oklahoma is people actually prefer to take 10 and five, uh, when their tolerance is built up.
[00:27:29] So they they’d rather buy that package over, you know, the 20 pack, you know, five and 2.5. Um, and as we see those ratio changes playing on the recreational medical side, we can make the adjustments for our products, uh, as our pricing comes down. Do
[00:27:45]Bryan Fields: you think that’s also something to do with the fact that.
[00:27:47] The markets that you’re talking about it a little more established in Oklahoma is a little newer. Could that play any difference where the consumer is always looking for more
[00:27:53]Eric Leslie: is better? Yeah. And I think the medical side of it too, I think that’s the framing. You gotta come in, man. It’s it is [00:28:00] hard to, you know, take your brain and turn it off for recreational back on to medical.
[00:28:03] We launched in Oklahoma. I had my recreational cap on, so our line was a hundred milligram products. Our best in that market now. Three years later, or are a thousand milligrams, a hundred milligrams for peaks. Like that’s what the market wants. Right. Um, you know, both on, on our gummies and our Tucson, um, you know, so it it’s turning the cap off and saying, um, you know, w what is the market.
[00:28:30] Um, is it medical is recreational. What w what can we get away with, you know, on the recreational side, but on medical is making sure that, you know, you have, while it might be new in Oklahoma, or newer may have these markers mature really, really fast, and they catch up. So the years it took to figure things out in Colorado market-wise regulation standards.
[00:28:49] It takes them a fraction of the time in Oklahoma to figure out that’s why you saw the boom that you did, because they learned the lessons from Colorado, very liberal regulations. Um, People [00:29:00] are different than they were in 2009, as far as their understanding of cannabis. I don’t care if you’re in a, um, you know, a market that allows them or not, you know, a whole lot more about cannabis now than you did in 2009.
[00:29:12] Um, and you know, that you’re looking for something different. So I think consumers are educated faster, um, and they’re figuring ways that dosage works for them specifically.
[00:29:23]Kellan Finney: I always been educating. Uh, cause you guys are kind of pioneering along with this minor cannabinoid. Formulations has been the, the educational Babylist said that.
[00:29:30] Have you noticed that the hill has been easier to climb every year and a new Marcus because of those factors you just mentioned.
[00:29:36]Eric Leslie: You’re a hundred percent, right. I was shocked at, uh, Massachusetts, you know, on, on east coast, which is our first flag on the east coast working over there. And we first launched like, oh, it’s a new market.
[00:29:47] Let’s go real slow. Just give them THC too complicated. They won’t understand, um, no way, man, like trifecta, sleepy, like they want. Right away. And I remember the talks early on were like, wow, do you guys [00:30:00] want to see the end product? Like, oh, I don’t know. Let’s just do THC and no. I mean, same thing. Those, those minors are popping up the very top of the pull through list.
[00:30:11] I think it’s a hundred percent consumers are way more savvy than we even realized, even in brand new markets. Way more educated. And if they’re not, it’s not taking them long to realize there’s more than THC. Um, you know, that’s going to give them, you know, what they’re ultimately looking for, you know, for themselves specifically,
[00:30:32]Bryan Fields: and, and even more on that is the brand staying power.
[00:30:34] Right. If you’ve been out to the west coast, Seeing these products, you know what you’re getting. And then when you go to Massachusetts and you see a hundred different products, 90, you haven’t seen, you want to lean on the ones you want, because when you do recommend to a friend, you want to recommend one that you like, and you know, it’s a lay up, right.
[00:30:49] If you’ve had the cheap, as you know, for sure you’re going to like them and it’s hard not to, they are absolutely delicious. So they, I mean, there, there’s no shame there. Ah, the live Roslyn products let’s talk about. [00:31:00]
[00:31:00]Eric Leslie: Sure. So, um, the other side of it, now that we’ve talked about, you know, we were isolating, um, you know, distilling down and reintroducing cannabinoids.
[00:31:10] The other trend we saw was actually out of California and there you go. Um, I’ll give a shout out to seven, 10 laps. Um, I got one of you guys tried their gummies. Yeah. This is not about seven 10, so boom, but no, not really because, um, I it’s funny during the podcast now we’ll send them an invoice. Yeah, exactly.
[00:31:31] Yeah. The podcast is sponsored by seven 10 lab. But in all honesty, um, you know, I was up in San Francisco. We’re, we’re kind of going through a market transition 2020 maybe or something like that. Um, you know, time just folds, but I was looking at the market market trends. I saw the seven, 10, um, gummies, what they call it.
[00:31:54] G U M M I, right. So they’re trying to be different with it. Uh, but there was no [00:32:00] flavor. It was literally like packed in, um, and rosin, you know, with some citric acid in it. That was it, um, was like, ah, give them a try, always try new products. And at first I was like, this is horrible. This is no, this is so bad.
[00:32:14] But then I allowed the gummy to break down and I’m like, no, this is too good. Like, there’s something here, a tasting the terpene, uh, take tasting the full profile of a solventless extract and then the effects. Right. Um, the, the entourage of it with those turpines, flavanoids all included in it, uh, really showed me something.
[00:32:33] I was like, oh, Actually, it’s not my lane. I’m not going to do a flavor list gummy and you know, their customers love it and that’s who that’s for. But there’s an opportunity to really look at Ross and assault that was extract, um, and how we can take a food plant experience and put it into an edible product.
[00:32:52] Uh, so we started looking at it and it took us a while. Um, because it’s a very artisinal process to [00:33:00] extract, uh, live rosin. Um, it is also a very artisanal process to infuse it into the right flavor of gummy or taffy or whatever it is. And then also finding the right partners in your state that do it at a high level and have the strains and with the terpene profile that, that fits the flavors that you have available to you.
[00:33:24] So we finally set a date and it was December of last year to launch our first, um, small batch strain, specific taffy. Um, and we used an Oreo strain and paired it with our strawberry taffy. Um, and, uh, it was delicious. And we’re like, yeah. Okay. Let’s go for it. That product sorta really quick. We did a really small batch just for December, came back in January, and I think we did a sour, apple space monkey, uh, pairing.
[00:33:54] Um, and, uh, it, that was another hit. And so we started seeing [00:34:00] some competence in the pull through of strain specific, right? This is one strain. Um, you know, all of it, at least solvent Listly extracted and infused with a very specific. Fruit taffy. What we also found is these strains don’t pair very well with our chocolates in our care, the way the turpines pull through in flavor and chocolate and caramel didn’t work very well.
[00:34:23] Um, so we really had to look at our fruit taffies. If you think about terpene profiles, that makes a lot of sense. The other side of it is when we looked at terpene profiles that had, uh, more gassy flavors to them, didn’t pair well at all, either. So again, painstaking process, you have to sample so many different strains.
[00:34:42] What a hard life it is, uh, to have to sample all of these products. I decided to delegate that one to our Colorado GM, uh, because you know, again, my tolerance levels, there’s no way. So, uh, Ryan, our Colorado OGs. Took the whole, um, of the R [00:35:00] D process because you generally have to write like it is, it is really hard to go get 7, 8, 9 strains.
[00:35:07] Um, and you know, at a very small five grand capacity, you know, mixing it into a small batch of TAPI and then sampling between a lemon Marangu sour, apple, or a strawberry decide. Which pairings are the best. Right. Um, and you’re really going on your pairings because the effects or the effects, it’s really on the flavor experience the taste of it, because you’re not trying to hide the turpines here.
[00:35:29] You know, for, for years, the industry has been trying to get the taste of candidness. And now we’re coming all the way backstage. No, no, no, no. We want you to experience the terpene taste, but you have to do it in a complimentary fashion that works well, you know, with, with the fruit taffy flavors. Um, so long story short, it takes so much research.
[00:35:51] Um, uh, in, are failing in combinations to make a straight specific live rosin product [00:36:00] work. Um, and, uh, it really is our T-SPOT, um, it really takes time and effort to do it right. You know, when we’re seeing. All right now is, um, you know, we’re seeing a proliferation of live rosin products coming out in different markets.
[00:36:14] What I fear most is people are just calling it live or Austin. Um, they’re not really doing the work to make sure that the terpene profile, um, and the flavor profile are matching To really let that straight shine. Um, and my concern is consumers are finding these products and they’re trying, and I’m saying, I don’t get, it just tastes Hashi.
[00:36:34] And it’s not what I was looking for. Um, you know, so we’re kind of combating against the proliferation, right? When you’re a market leader, you’d go to market with it. You’ll see a lot of other competitors jump in as fast as they can. Um, and I would caution anyone thinking about doing it to make sure you have the time and effort, uh, and Dan with, to do the testing process.
[00:36:54] Because Every quarter, we released a new, small batch, you know, straight, specific taffy. [00:37:00] And, uh, we spend, you know, three weeks working on sourcing the right, uh, live rosin, stray, um, and making sure it pairs properly, you know, with the right taffy flavor, uh, before we even consider, you know, buying a kilo of it. Yeah.
[00:37:15] And doing a batch. So, um, it is a painstaking process to get it right, because boy, if you get it wrong, you’re just giving somebody something that’s Hashi and burns your throat. Why did I just pay extra for that? Um, so that’s really what led us into live rosin and appreciation. And I think a deeper appreciation for, uh, the process it takes to extract, you know, solvent, Leslie, um, maintain the Terp profile and the appreciation that, that consumers that enjoy that live rosin.
[00:37:44] Um, making sure we’re paying respects to it, um, in the way that we’re infusing it into our products.
[00:37:50]Kellan Finney: Personally, I think that those are my favorite animal product. Our live Ross and products. And I think that, um, traditionally, you know, back in the day, the animals weren’t available. [00:38:00] So Jesse cannabis was through smoking and flour.
[00:38:02] Right. And I think live rosin is the closest edible to a flower experience that you can possibly have. And it just goes back to the fact that it’s solvent lists. There’s no kinetic energy Dysport into it. You’re really just trying to capture that chemical profile associated with the flower and then reintroduce it in a different form factor.
[00:38:21] And so I think at the end of the day, that’s probably one of the. Um, powerful products on the market because yeah, you’re going to see all these kinds of copycats and marketing kind of games being played. But at the end of the day, what a consumer eats a live rosin product and it’s made the right way.
[00:38:36] They’re going to know. And the experience is far and above better in my personal experience than
[00:38:41]Bryan Fields: other edibles. When you say it’s closest, do you mean by taste or byline experience experience? So
[00:38:46]Kellan Finney: like when you eat, there’s some animals that are just. Like just so this, it goes back to the mirror and all.
[00:38:51] So Marinol is one of the first synthetic THC pharmaceutical drugs out there. And a lot of people that were taking it instead of like smoking flower that were on [00:39:00] chemotherapy, did not have the same experience. They weren’t experiencing the hunger. They weren’t getting like all these other benefits that they were supposed to from the cannabis associated with the chemotherapy treatment.
[00:39:10] And, and it just has to do with that entourage effect. And so there are animals that are just strictly THC and it’s a completely different experience. And some people really until. That just isolate experience, but it is very different than a flower experience because you’re missing the entourage effect associated with that strain.
[00:39:28] And so that’s really the
[00:39:29]Eric Leslie: difference. And I think when you say entourage, you know, you’re like you’ve said, I think Terpy w we, we need to study it more, this scientific benefits of the vaccine therapies, right? Like there’s no scientific that everybody thinks it’s just for flavor. Turpines hit man. Like, I mean, it, it it’s real.
[00:39:48] We just don’t have the scientific data to back it, to make the claims. Right. Um, you know, we talk about, I’m going to do selfish promotion here because we also our new live [00:40:00] Roz and melts. Um, so these guys are not strain specific. Uh, But what we do is we, we pulled together multiple strings that have similar terpene profiles.
[00:40:12] Um, and you’ll see, you know, in each piece, you know, we’ve got an actual, it’s got a turret profile in there. One of
[00:40:18]Kellan Finney: the best ways I’ve seen that.
[00:40:21]Eric Leslie: That’s pretty straight forward. And so what we do is, you know, all of our melts, you know, we got our, uh, strawberry, um, in Africa, I know smart, right? Toasted coconut on the flavor.
[00:40:33] So, but each batch uses the same blended Raj it’s really, you’re, you’re looking at, you know, from batch to batch, you know, you’re going to have the same. My live rosin oil mix in here until, you know, we move on to the next batch, but it’s important because that mix is complimentary to each one of those flavors.
[00:40:53] You know, these melts it’s a packet of fruit, so it’s basically a fruit juice. Uh, is what it is. And we’re [00:41:00] taking, this is our first all natural vegan friendly product, um, and stripping it down and saying, you know, if you really want to experience the live rosin impact, let’s strip everything else out and pair it with.
[00:41:14] And a little bit of pectin and some shoulder, right. And that’s really what this product is. Um, it’s a lot, it’s not a strain specific. Um, it’s taking specific strains, blending them together that have complimentary terpene profiles, um, and making sure. It is enhanced by the fruit jam that were refused to get into.
[00:41:34] Um, and that’s, you know, same thing, then it is the full experience. You’re trying to give somebody that, that is as true to the plan as possible. Um, and that’s exactly what we did, you know, with these smells products
[00:41:45]Bryan Fields: for the 99% of the people who are going to listen to this. Can you explain to them what that graph.
[00:41:49] Yeah, the
[00:41:50]Kellan Finney: infographic, how you display once it interprets it’s phenomenal because it’s so hard to communicate that information is
[00:41:56]Eric Leslie: yeah. So, you know, really, and, and, you know, we didn’t [00:42:00] mark the actual numbers in there, right? Like, you know, what the percentage is, but really, it just kind of shows what the dominant terpene is.
[00:42:07] Um, and so you can, we really encourage our customers. To be educated about the buying experience and why this was important for us is because we are seeing a proliferation of live Roslyn products out there. And what did I tell you is it’s a really delicate process to keep your TURPs in your oil when you’re heating it up.
[00:42:25] Right? Cause that’s. He does it bakes off your TURPs? So it’s a really delicate process to heat up the oil enough to infuse it, but not overdoing it to bake all the TURPs off. Um, so what was important for us is to prove it. Um, and so all of our batches, we also get a Turk profile. Um, and then we take that profile, um, and we printed it onto our cards for you here.
[00:42:46] Right. So you can kind of see, oh man, I really love the way that. Chased it and felt it. And now you can see what the turpines were in that blend in order to give you a better idea of how TURPs [00:43:00] affect your overall experience. Right. Um, we also put in the strains, you know, those are the dominant strains.
[00:43:05] There there’s a couple of other ones, but these were the top three straights because they man love. Th the aroma I’d love the taste. I love the effects. What types of strains are going to give me that, uh, so that we can educate consumers to say they’re always looking for what works best for them personally, what’s going to impact me.
[00:43:22] We’re also unique in how cannabis impacts us. When we find those connections, we want to hold on to them and educating them of, of what the term profile is in this specific batch and what strains, um, contributed to that effect. Um, as part of that education process that we want to make sure our consumers understand it, and there are powered by it.
[00:43:43] It’s such a nice
[00:43:43]Bryan Fields: touch, right? Cause after you consume one of those and you’re like this. Delicious. Why am I tasting you open up the container and you see that? And you’re like, oh, this is exactly what it is. And then it allows them to bring it back to wherever they go next and use that as a guide to hopefully replicate that experience, which is probably super, super [00:44:00] helpful.
[00:44:00] And
[00:44:00]Kellan Finney: also too, I mean, there’s like, uh, turpines are a huge part of Roma therapy. And so if you’re looking to relax and you’re like, Hey, I love lavender. And I know the major terpene and lavender, and you’re looking for that. It gives you something to grab onto. To then create that experience you’re looking for.
[00:44:16] So I love it.
[00:44:17]Eric Leslie: Well, I think most importantly guys is, is accountability because the more you see libraries and products out there that can’t prove a terpene profile, you’re not dealing with a live rosin product. If it’s a fast acting, there’s no way like you can’t do all of these things and put it into a product.
[00:44:34] Like it’s a very artisinal natural process to get live. Roger. Your heat and pressure. So all you’re doing there, guys to get it. Did you get an in there, if you can’t prove the profile in your edible and you can’t taste it and you can’t see it, um, you’re going to have consumers. That question is this. Live Ross.
[00:44:55] And what was most important to us is to defeat that narrative of like, is it live [00:45:00] roster or not? Like you just have to look at the profiles and you’re going to see what’s in there and then you’re going to taste it and that’s going to back it up. So I think that was really important for us to show it every single time you open your container, you’re going to see what the profile is in there.
[00:45:13] There’s no hiding from it. Our batch test results, show it in there. And I challenge all of our competitors to do. Thanks so that we build trust into the validity of a live rock product.
[00:45:25]Bryan Fields: Eric, what is one fact or statistic that would shock the outside industry about the edible industry or about the edible process?
[00:45:33]Eric Leslie: Oh man. Um, what’s one fact, um, um, I think probably the amount of oil necessary, uh, to get you high. Um, what, when people think a hundred, you know, when you feel the effects of 10 milligrams or a hundred milligrams, That word milligram, like there’s so little amount. Um, and, and when you look at, you know, distilling down [00:46:00] THC, um, the reason why, and this is the crazy part that I hear people talking about potency caps, right.
[00:46:06] Um, okay. Understand it On concentrates, flower, whatever, but it only hurts an edible to cap the pokes because if I have a 95% THC, um, cannabis oil, that means I have to use less oil in the animal to achieve 10 milligrams. If I have a 50%. Potency or 30% oil potency, um, on the oil I got to put in my taffy, it’s going to be sludge because you have to put so much more oil in it to get to 10 milligrams, 10 milligrams, 10 milligrams.
[00:46:39] It’s better. If the oil pokes, he put it into it is 99% or 10% the higher, the quality of the oil. The more efficient you can be in the mountain, you have to put into the edible. And I hate all of these regulations that go around talking about tapping the potency of oil that you’re going to put an edible, because all you’re doing is ruining the consumer [00:47:00] experience by having we put war oil into the same edible or to achieve the same 10 milligrams
[00:47:06]Bryan Fields: since you’ve been in the cannabinoid industry, what has been the biggest mistake?
[00:47:11]Eric Leslie: Um,
[00:47:15] biggest misconception. Um, you know, I, I think it’s what I hate most now. Like I’ve been here so long, right. So if you asked me 10 years ago, Isn’t that what it is now? I think the biggest misconception is, uh, um, what the industry is really all about, uh, sitting here and talking to you guys, we’ve been around a long time and our mission is to serve our customers.
[00:47:39] You know, we’re best value we can. Uh, what I hate to see is the loudest people in the room are usually the least qualified. Um, you know, when it comes to our industry and we’re seeing a lot of. Pour it into multi-state operators. What they’re doing is they’re hiring consultants that like me, that have worked here and have done all the hard work to get [00:48:00] here, to help them build their business a little bit differently.
[00:48:03] Right. Um, they’re buying them out. Um, and, uh, they’re using them as consultants to, to build even further the roots of who we are, the identity of our industry. Um, you know, there’s a lot of people. That need to speak up. And I think a misconception is that we’re not here. Uh, we’ve been here all along, um, and we’re continuing to do the job.
[00:48:22] It’s just, we’re not the loudest guys in the room anymore because the room got a whole lot bigger and there’s a lot more money sitting inside the room because as, as we creep closer towards federal legalization or multi-state, you know, continue to grow on, you’re going to find. That that money is sitting on the sidelines.
[00:48:38] It’s a little less risky and they’re going to take more of a chance on it, but we’re still here. We’re still working for the customer’s best interests. Um, you just gotta be really smart about being able to identify as the marketplace. Now,
[00:48:51]Bryan Fields: before we do predictions, we ask all of our guests, if you could sum up your experience in a main takeaway or lesson learned to pass onto the next generation, what [00:49:00] would it be?
[00:49:01]Eric Leslie: Okay. I think we talked about a little bit earlier. I think resiliency is so important. It’s a life lesson. If I didn’t, if I didn’t, um, you know, do this for the last 12 years, I’ve had many opportunities to quit and walk away. Um, and, uh, you know, when I come back to is this is a once in a generation opportunity to create an industry.
[00:49:22] Um, it did take that responsibility, um, uh, Um, very, uh, it’s incredibly important that we take it serious, what we’re doing here, because we are creating legacies right in front of our eyes. Um, and you’re going to fail. Um, you’re going to fall hard. Um, and in your ability to get back up, it’s such a cliche thing, but to you go through it, continue to fall down and have to get back up.
[00:49:49] You don’t realize the value of doing it. Um, the journey is. Important as the destination and while I don’t know exactly where we’re going to end up, what I do know is every opportunity we [00:50:00] have to create an industry and be a part of it. Like this is a blessing. Um, you know, you’re never going to get an opportunity to do this in your lifetime.
[00:50:06] So, so take that. Um, you know, in honor it right. Uh, don’t look at it as a cash cow or an opportunity to make as much money as you can look at it and say, man, I have an opportunity to make a real societal difference. I can change the perception of society around a plant. Um, that for years for decades have been told it’s it’s bad and it’s dangerous.
[00:50:28] When, when in reality it’s an opportunity to really help people, um, and make sure that we’re honoring that first and foremost above anything else we do. That’s really well said,
[00:50:40]Bryan Fields: Herrick it’s 20, 28. How will Edel edibles be marketed to consumers by flavors, cannabinoids, or modality?
[00:50:50]Eric Leslie: Um, Yeah, that’s a good question.
[00:50:54] Um, it’s not going to be flavors cause there’s so many goddamn flavors, uh, out there already. People are fatigued by [00:51:00] flavors, right? I think we offer preference, but no way. Um, you know, I think I genuinely believe, um, and it’s not because I have an amazing wellness line that is booming and everybody needs to try it, but I really believe, um, our cannabinoids.
[00:51:14] Uh, change lives. Um, I think, you know, the, the term we came up with earliest, minor cannabinoids are made with major effects, right? When we start really looking even deeper. I mean, we’re, we’re looking at CBC right now. We launched a, um, an energy chew with our THC B product. Uh, when we start looking even deeper, CBDA CPO, like there are so many different minor cannabinoids.
[00:51:36] Um, we have. Scratch the surface on what these ratio combinations can really do for people. Um, my hope is by that time we’ve done the real research and we’ve vetted through all the BS. Um, and we have products on the market that can really help people in their very specific needs of I’m going to say adenoids ma’am.[00:52:00]
[00:52:00]Kellan Finney: Ronnie, and I’m going to go cannabinoid stupid. I’m going to go with, uh, instead of cannabinoids, I think it’s going to be a step further away from distinguishing the difference between cannabinoids, right? Like right now, people, I guarantee you, if you ask 10 people, nine of them, couldn’t tell you the difference between Tylenol and ibuprofen.
[00:52:15] And there is very different chemicals in both of those drugs. And so I think at the end of the day, uh, it’s going to kind of have. The one degree away from exactly where, what can I do in there? And it’s going to be more of an experience situation. Like the energy, like yeah. Lifting like the relaxing kind of aspect.
[00:52:33] But I think that there will be hard science that ties that experience to specific inoperative formulations. All right. What
[00:52:40]Bryan Fields: do you think, Brian? Yeah, that’s that’s the one I was going to take. I think that people need to recognize. People don’t just consume ConAgra and it’s just to get super high, right?
[00:52:48] There’s that creative rush. And until you find that product that inspires and just kind of like, lets you out from a creative standpoint, I think it’s hard to really explain to others because it’s like a [00:53:00] whole nother dimension of, of freedom. And, and once people unlock that area, I think it’s really going to surprise people.
[00:53:05] And I think once we get that science research that backs it up and people can find those products and say, Hey, I want to take that microdose product. Or I want to take this energy of product. And then it. I can take my sleep product and there’s no confusion with them. I, I think it’s going to freak people out.
[00:53:19] I really think people are, have no idea what’s coming for them. And I’m really excited, you know, for that next step when we get there. So Eric, for all of our east coast listeners and others out there who, who want to get in touch and they want to buy your products, where can they go?
[00:53:32]Eric Leslie: Right now it’s time for a vacation to Colorado guys.
[00:53:36] Um, you can go to Massachusetts, you can go to Massachusetts. It’s going to be five milligrams across the board. Talk to your late your state regulators. If you got a problem with that cap, I do, but I’m not lobbying for you. Um, we are, um, in Oklahoma, uh, we’re in Nevada. We’re in California. We’re launching in Missouri next month.
[00:53:57] I’m going to keep going down the west coast Che [00:54:00] we’re going to New Mexico. We’re also looking at Montana. So sorry, Brian. Uh, we are really close in New York, but New York is a shit show and good luck getting regulations for us to be able to distribute their buddy. Um, but I’d love to get to New York next.
[00:54:17] I think that’s. Well on the east coast, that’s probably the one we’re closest with. We’re talking to a couple parties that, you know, are going to be able to onboard before, you know, distributor license are out and that sort of stuff. We’re hopeful for it. But man, I’ll tell you what, it’s messy. I think. Just to real quickly on that.
[00:54:37] I think when New York and New Jersey turned on, I think we’ll hit our tipping point because of the way it’s going to export out of those two states. We go right down the Eastern seaboard. I think, uh, the states are gonna have no option, but to regulate or to legalize and regulate themselves so that they’re collecting those tax dollars.
[00:54:53] Yeah. New, new
[00:54:53]Bryan Fields: Jersey’s live right now. And I know a lot of friends who have made the trip across the bridge because yeah. They want [00:55:00] to get what they want to get. So it’s
[00:55:01]Eric Leslie: so easy. Yeah.
[00:55:02]Bryan Fields: It’s, it’s unfortunate, but yeah, maybe, maybe by the time this airs we’ll have good news. I’m very doubtful of that, but Hey, I can always help.
[00:55:09] So Eric, thanks so much for your time. Talk to you soon.
[00:55:12]Eric Leslie: Take care of.
